[Michael DeVries]

The following are some resources, references, links, etc. to help you learn how to develop Conversational Interfaces / Chatbots:

• The Alexa Skills Kit => https://developer.amazon.com/alexa-skills-kit/learn
• Storyline => https://getstoryline.com/
• Alexa Skills BluePrints => https://blueprints.amazon.com/
• Google Dialogflow => https://developers.google.com/actions/dialogflow/first-app

What other resources, references, links, etc. to help you learn how to develop Conversational Interfaces / Chatbots have you found / do you know about?

Let’s share them all herein, ok?

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

“This 22-year-old college student makes $10,000 a month off Amazon’s Alexa” => https://www.cnbc.com/2018/04/12/student-makes-10000-a-month-inventing-skills-for-amazon-alexa.html

What do you think about that?

Does anyone else have some examples and/or references regarding people already making good money developing components of conversational interfaces?

Let’s discuss it all herein, ok?

Please find opportunities to benefit/profit from your skills in developing anything related to Conversational Interfaces / Chatbots at: http://blog.thevcf.com/forums/forum/v-i-b-e-s-project-forums/

I hope this all helps and Have a Great Day!

– Michael S. DeVries

• This reply was modified 6 years, 7 months ago by Michael DeVries.
• This reply was modified 6 years, 7 months ago by Michael DeVries.
• This reply was modified 6 years, 7 months ago by Michael DeVries.
• This reply was modified 6 years, 7 months ago by Michael DeVries.

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 04/30/2018 – 05/04/2018:

1) TIK – Tel-Instrument Electronics Corp.
a. Buy at < ~ $2.05
b. Sell at >~ $3.85

2) SUNW – Sunworks, Inc.
a. Buy at < ~ $0.90
b. Sell at >~ $1.45

3) PRSS – CafePress Inc. – Trading Below Cash
a. Buy at < ~ $1.26
b. Sell at >~ $1.99

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/30/2018 - 05/04/2018, and Why?

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 04/20/2018 include:

1. $CECE – CECO Environmental Corp. :
   1. Book/sh = $5.17
2. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $1.73
3. $DCAR – DropCar, Inc. :
   1. Book/sh = $3.01
4. $KOOL – Cesca Therapeutics Inc. :
   1. Book/sh = $3.36
5. $OVAS – OvaScience, Inc. :
   1. Book/sh = $1.80
6. $ROSG – Rosetta Genomics Ltd. :
   1. Book/sh = $0.43
7. $VICL – Vical Incorporated :
   1. Book/sh = $3.29

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 04/20/2018 include:

1. $BVSN – BroadVision, Inc. :
   1. Cash/sh = $2.26
2. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.95
3. $DCAR – DropCar, Inc. :
   1. Cash/sh = $1.92
4. $EGLT – Egalet Corporation :
   1. Cash/sh = $2.31
5. $FCSC – Fibrocell Science, Inc. :
   1. Cash/sh = $0.77
6. $OPHT – Ophthotech Corporation :
   1. Cash/sh = $4.63
7. $OVAS – OvaScience, Inc. :
   1. Cash/sh = $1.88
8. $VICL – Vical Incorporated :
   1. Cash/sh = $2.67
9. $VVUS – VIVUS, Inc. :
   1. Cash/sh = $2.14

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 04/23/2018 – 04/27/2018:

1) TIK – Tel-Instrument Electronics Corp.
a. Buy at < ~ $2.06
b. Sell at >~ $3.85

2) BVSN – BroadVision, Inc.
a. Buy at <~ $2.30
b. Sell at >~ $3.15

3) PRSS – CafePress Inc. – Trading Below Cash
a. Buy at < ~ $1.30
b. Sell at >~ $1.99

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/23/2018 – 04/27/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 04/09/2018 – 04/13/2018:

1) TIK – Tel-Instrument Electronics Corp.
a. Buy at < ~ $2.06
b. Sell at >~ $3.85

2) TISA – Top Image Systems Ltd.
a. Buy at < ~ $0.95
b. Sell at >~ $1.53

3) TTNP – Titan Pharmaceuticals, Inc.
a. Buy at < ~ $0.94
b. Sell at >~ $1.40
c. Catalysts:
1. Phase 1/2 treatment has commenced – noted October 11, 2017. Data from first patient cohort due 1H 2018. – Ropinirole implant – Parkinson’s disease – Phase 1/2; 20180630; 20180630; https://ir.titanpharm.com/all-sec-filings/content/0001144204-18-001164/tv482843_ex99-1.htm
2. Phase 2 – Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome; 20180301; 20190331; https://ClinicalTrials.gov/show/NCT02867878
3. Phase 1Phase 2 – Relative Bioavailability Study of Ropinirole Implants in Parkinsons Patients on L-Dopa Switched From Oral Ropinirole; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT03250117
4. Phase 3 – A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC; 20201104; 20220713; https://ClinicalTrials.gov/show/NCT02489318
5. Phase 2 – Immunological and Regenerative Implications of Corrosion of Dental Materials in Children and Adolescents; 20181231; 20191230; https://ClinicalTrials.gov/show/NCT03334461

4) BVSN – BroadVision, Inc.
a. Buy at < ~ $2.30
b. Sell at >~ $3.15

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/09/2018 – 04/13/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 04/02/2018 – 04/06/2018:

1) SEED – Origin Agritech Limited
a. Buy at < ~ $0.74
b. Sell at >~ $1.50

2) TISA – Top Image Systems Ltd.
a. Buy at < ~ $0.95
b. Sell at >~ $1.53

3) TTNP – Titan Pharmaceuticals, Inc.
a. Buy at < ~ $0.94
b. Sell at >~ $1.40
c. Catalysts:
1. Phase 1/2 treatment has commenced – noted October 11, 2017. Data from first patient cohort due 1H 2018. – Ropinirole implant – Parkinson’s disease – Phase 1/2; 20180630; 20180630; https://ir.titanpharm.com/all-sec-filings/content/0001144204-18-001164/tv482843_ex99-1.htm
2. Phase 2 – Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome; 20180301; 20190331; https://ClinicalTrials.gov/show/NCT02867878
3. Phase 1Phase 2 – Relative Bioavailability Study of Ropinirole Implants in Parkinsons Patients on L-Dopa Switched From Oral Ropinirole; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT03250117
4. Phase 3 – A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC; 20201104; 20220713; https://ClinicalTrials.gov/show/NCT02489318
5. Phase 2 – Immunological and Regenerative Implications of Corrosion of Dental Materials in Children and Adolescents; 20181231; 20191230; https://ClinicalTrials.gov/show/NCT03334461

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/02/2018 – 04/06/2018, and Why?

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 03/23/2018 include:

1. $CECE – CECO Environmental Corp. :
   1. Book/sh = $5.17
2. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $2.39
3. $DCAR – DropCar, Inc. :
   1. Book/sh = $3.01
4. $OVAS – OvaScience, Inc. :
   1. Book/sh = $2.03
5. $ROSG – Rosetta Genomics Ltd. :
   1. Book/sh = $0.43
6. $VICL – Vical Incorporated :
   1. Book/sh = $3.29

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 03/23/2018 include:

1. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $2.16
2. $EGLT – Egalet Corporation :
   1. Cash/sh = $2.31
3. $OPHT – Ophthotech Corporation :
   1. Cash/sh = $4.90
4. $OVAS – OvaScience, Inc. :
   1. Cash/sh = $2.22
5. $VICL – Vical Incorporated :
   1. Cash/sh = $2.67
6. $VVUS – VIVUS, Inc. :
   1. Cash/sh = $2.23

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

[Michael DeVries]

“Things I’ve Learned After 15 Years Of Trading” => http://theimpatienttrader.blogspot.com/2011/10/things-ive-learned-after-15-years-of.html

What do you think about all of those?

Let’s discuss them all herein, ok?

I hope this all helps. Good Luck! and Have a Great Trading Day!

– Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 03/19/2018 – 03/23/2018:

1) GSAT – Globalstar, Inc.
a. Buy at < ~ $0.70
b. Sell at >~ $2.59

2) TWMC – Trans World Entertainment Corporation
a. Buy at < ~ $1.50
b. Sell at >~ $3.10

3) TISA – Top Image Systems Ltd.
a. Buy at < ~ $0.96
b. Sell at >~ $1.53

4) CYCC – Cyclacel Pharmaceuticals, Inc. – Trading Below Cash
a. Buy at < ~ $1.47
b. Sell at >~ $2.15
c. Catalysts:
1. Phase 1 – A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors; 20180701; 20180731; https://ClinicalTrials.gov/show/NCT00999401
2. A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors; 20180701; 20180731; https://www.clinicaltrials.gov/ct2/show/NCT00999401?term=Cyclacel&recr=Open&rank=2
3. Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation (ROSCO-CF); 20180801; 20181031; https://www.clinicaltrials.gov/ct2/show/NCT02649751?term=Cyclacel&recr=Open&rank=3
4. Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) Phase 2; 20190701; 20190731; https://www.clinicaltrials.gov/ct2/show/NCT01253460?term=Cyclacel&rank=11
5. Phase 2 – Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23); 20190701; 20190731; https://ClinicalTrials.gov/show/NCT01253460

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 03/19/2018 - 03/23/2018, and Why?

[Michael DeVries]

“12 Insights from “The Most Important Thing” by Howard Marks” => https://marketwisdom.com/12-insights-from-the-most-important-thing-by-howard-marks/

What do you think about those insights?

Let’s talk about it all herein, ok?

I hope this helps! Good Luck! and Have a Great Trading Week!

– Michael S. DeVries

[Michael DeVries]

How fast should be your learning curve as a trader? Some hard numbers: https://traderfeed.blogspot.com/2018/03/how-fast-is-learning-curve-for-traders.html

Where are you in your learning curve as a trader?

If you are now making your living trading, then:
1) How long did it take you to be able to make a living (just) trading?
2) What advice and/or Lessons Learned would you be willing and able to share to help others be able to make their living (just) trading?

Let’s talk about it all herein, ok?

I hope this helps! Good Luck! and Have a Great Trading Week!

– Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 03/05/2018 – 03/09/2018:

1) TTPH – Tetraphase Pharmaceuticals Inc – Trading Below Cash
a. Buy at < ~ $2.05
b. Sell at >~ $7.95
c. Catalysts:
1. Phase 1 – A Phase 1 TP-271 Oral PK Single Ascending Dose Study; 20171201; 20180531; https://ClinicalTrials.gov/show/NCT03024034
2. Phase 1 – A Phase 1 Safety and PK Study of IV TP-271; 20180331; 20180430; https://ClinicalTrials.gov/show/NCT03234738
3. Phase 3 – Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT03032510

2) TWMC – Trans World Entertainment Corporation
a. Buy at < ~ $1.50
b. Sell at >~ $3.10

3) TISA – Top Image Systems Ltd.
a. Buy at < ~ $0.96
b. Sell at >~ $1.53

4) CYCC – Cyclacel Pharmaceuticals, Inc. – Trading Below Cash
a. Buy at < ~ $1.47
b. Sell at >~ $2.15
c. Catalysts:
1. Phase 1 – A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors; 20180701; 20180731; https://ClinicalTrials.gov/show/NCT00999401
2. A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors; 20180701; 20180731; https://www.clinicaltrials.gov/ct2/show/NCT00999401?term=Cyclacel&recr=Open&rank=2
3. Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation (ROSCO-CF); 20180801; 20181031; https://www.clinicaltrials.gov/ct2/show/NCT02649751?term=Cyclacel&recr=Open&rank=3
4. Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) Phase 2; 20190701; 20190731; https://www.clinicaltrials.gov/ct2/show/NCT01253460?term=Cyclacel&rank=11
5. Phase 2 – Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23); 20190701; 20190731; https://ClinicalTrials.gov/show/NCT01253460

5) AST – Asterias Biotherapeutics, Inc.
a. Buy at < ~ $1.95
b. Sell at >~ $2.30
c. Catalysts:
1. Phase 1/2 six-month top-line data due June 2018 with 12-month data due December 2018. 6-month data from Cohort 3 (AIS-A 20 million-cell cohort) and Cohort 4 (AIS-B 10 million-cell cohort) due February 2018, and the 12-month data from Cohorts 3 and 4 in August 2018. – AST-OPC1 SCiSTAR – Cervical spinal cord injury – Phase 1/2; 20180801; 20180831; https://finance.yahoo.com/news/asterias-biotherapeutics-reports-milestone-targets-125200132.html
2. Phase 1Phase 2 – Dose Escalation Study of AST-OPC1 in Spinal Cord Injury; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT02302157
3. Phase 1/2 trial to be initiated 1H 2018 with initial safety and immunogenicity readouts due 2H 2018. – AST-VAC2 – Non-small cell lung cancer (NSCLC) – Phase 1/2; 20181231; 20181231; http://asteriasbiotherapeutics.com/inv_news_releases_text.php?releaseid=2324856&date=January+04%2C+2018&title=Asterias+Biotherapeutics+Reports+Milestone+Targets+for+2018

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 03/05/2018 - 03/09/2018, and Why?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/19/2018 – 02/23/2018:

1) TTPH – Tetraphase Pharmaceuticals Inc – Trading Below Cash
a. Buy at < ~ $2.10
b. Sell at >~ $7.95
c. Catalysts:
1. Phase 1 – A Phase 1 TP-271 Oral PK Single Ascending Dose Study; 20171201; 20180531; https://ClinicalTrials.gov/show/NCT03024034
2. Phase 1 – A Phase 1 Safety and PK Study of IV TP-271; 20180331; 20180430; https://ClinicalTrials.gov/show/NCT03234738
3. Phase 3 – Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT03032510

2) TWMC – Trans World Entertainment Corporation
a. Buy at < ~ $1.50
b. Sell at >~ $3.10

3) TISA – Top Image Systems Ltd.
a. Buy at < ~ $0.96
b. Sell at >~ $1.53

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/19/2018 – 02/23/2018, and Why?

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 02/09/2018 include:

1. $AVIR – Aviragen Therapeutics, Inc. :
   1. Cash/sh = $0.86
2. $EGLT – Egalet Corporation :
   1. Cash/sh = $2.21
3. $OPHT – Ophthotech Corp :
   1. Cash/sh = $5.46
4. $OVAS – OvaScience Inc :
   1. Cash/sh = $2.08
5. $VICL – Vical Incorporated :
   1. Cash/sh = $2.68
6. $VVUS – VIVUS, Inc. :
   1. Cash/sh = $2.23

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 02/09/2018 include:

1. $CECE – CECO Environmental Corp. :
   1. Book/sh = $5.17
2. $JAGX – Jaguar Health, Inc. :
   1. Book/sh = $0.57
3. $KZIA – Kazia Therapeutics :
   1. Book/sh = $21.56
4. $NFEC – NF Energy Saving Corporation :
   1. Book/sh = $3.83
5. $OVAS – OvaScience Inc :
   1. Book/sh = $2.03
6. $ROSG – Rosetta Genomics Ltd. (USA) :
   1. Book/sh = $2.40
7. $VICL – Vical Incorporated :
   1. Book/sh = $3.29

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/15/2018 – 01/19/2018:

1) EGLT – Egalet Corp – Trading Below Cash
a. Buy at < ~ $0.80
b. Sell at >~ $1.38

2) VICL – Vical Incorporated – Trading Below Cash
a. Buy at < ~ $1.66
b. Sell at >~ $2.70
c. Catalysts:
1. Initiated Phase 3 Jun 2013. Enrollment due to be completed 3Q 2016. Topline data due 1Q2018. – ASP0113 Vaccine – Hematopoietic cell transplant recipients – Phase 3; 20180101; 20180331; http://www.vical.com/investors/news-releases/News-Release-Details/2016/Vical-Reports-Third-Quarter-2016-Financial-Results/default.aspx
2. Phase 3 trial completion announced November 10, 2017. Top-line data due 1Q 2018. – ASP0113 Vaccine – Hematopoietic cell transplant recipients – Phase 3; 20180331; 20180331; http://www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Reports-Third-Quarter-2017-Financial-and-Operational-Results/default.aspx
3. Phase 2 trial initiated September 2016. Enrollment completion announced April 19, 2017 with data due 2Q 2018. – VCL-HB01 HSV-2 Therapeutic Vaccine – Genital Herpes in Adults – Phase 2; 20180630; 20180630; http://www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Reports-Third-Quarter-2017-Financial-and-Operational-Results/default.aspx

3) IMDZ – Immune Design Corp
a. Buy at < ~ $3.50
b. Sell at >~ $5.30
c. Catalysts:
1. Phase 1 – Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers; 20180430; 20190430; https://ClinicalTrials.gov/show/NCT02642809
2. Phase 1 – Dose-seeking and Efficacy Study of Pembrolizumab Plus Vemurafenib Advanced Melanoma; 20180601; 20181031; https://ClinicalTrials.gov/show/NCT02818023
3. Phase 1Phase 2 – Study of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkins Lymphoma; 20171201; 20180331; https://ClinicalTrials.gov/show/NCT02501473
4. Phase 1 – Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1; 20171231; 20200811; https://ClinicalTrials.gov/show/NCT02122861
5. Phase 1 – Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200); 20190801; 20190831; https://ClinicalTrials.gov/show/NCT02043665
6. Phase 1Phase 2 – Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer; 20190801; 20200831; https://ClinicalTrials.gov/show/NCT02963610
7. Phase 2 – Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer; 20180901; 20190930; https://ClinicalTrials.gov/show/NCT02981303
8. Phase 2 – Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma; 20190101; 20190630; https://ClinicalTrials.gov/show/NCT02736266

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/15/2018 – 01/19/2018, and Why?

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 01/05/2018 include:

1. $NFEC – NF Energy Saving Corporation :
   1. Book/sh = $3.83
2. $PERI – Perion Network Ltd :
   1. Book/sh = $2.21
3. $ROSG – Rosetta Genomics Ltd. (USA) :
   1. Book/sh = $2.40

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 01/05/2018 include:

1. $AVIR – Aviragen Therapeutics, Inc. :
   1. Cash/sh = $0.86
2. $FCSC – Fibrocell Science Inc :
   1. Cash/sh = $1.35
3. $OPHT – Ophthotech Corp :
   1. Cash/sh = $5.46
4. $VVUS – VIVUS, Inc. :
   1. Cash/sh = $2.23

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/08/2018 – 01/12/2018:

1) EGLT – Egalet Corp – Trading Below Cash
a. Buy at < ~ $0.80
b. Sell at >~ $1.38

2) VICL – Vical Incorporated – Trading Below Cash
a. Buy at < ~ $1.66
b. Sell at >~ $2.70
c. Catalysts:
1. Initiated Phase 3 Jun 2013. Enrollment due to be completed 3Q 2016. Topline data due 1Q2018. – ASP0113 Vaccine – Hematopoietic cell transplant recipients – Phase 3; 20180101; 20180331; http://www.vical.com/investors/news-releases/News-Release-Details/2016/Vical-Reports-Third-Quarter-2016-Financial-Results/default.aspx
2. Phase 3 trial completion announced November 10, 2017. Top-line data due 1Q 2018. – ASP0113 Vaccine – Hematopoietic cell transplant recipients – Phase 3; 20180331; 20180331; http://www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Reports-Third-Quarter-2017-Financial-and-Operational-Results/default.aspx
3. Phase 2 trial initiated September 2016. Enrollment completion announced April 19, 2017 with data due 2Q 2018. – VCL-HB01 HSV-2 Therapeutic Vaccine – Genital Herpes in Adults – Phase 2; 20180630; 20180630; http://www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Reports-Third-Quarter-2017-Financial-and-Operational-Results/default.aspx

3) OVAS – OvaScience Inc – Trading Below Cash
a. Buy at < ~ $1.25
b. Sell at >~ $1.56
c. Catalysts:
1. OvaPrime study – reintroductions completed by the end of H1 2018; 20180101; 20180630; https://seekingalpha.com/news/3273112-ovascience-completes-enrollment-ovaprime-study
2. OvaScience to Present at the 36th Annual J.P. Morgan Healthcare Conference; 20180111; 20180111; https://finance.yahoo.com/news/ovascience-present-36th-annual-j-120000121.html
3. NA – Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure; 20220601; 20220630; https://ClinicalTrials.gov/show/NCT03021915

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/08/2018 – 01/12/2018, and Why?

[Michael DeVries]

What are all of your Lessons Learned from Trading during 2017?

What Resolutions are you going to make to improve your trading performance for 2018?

Happy New Year and Wishing You All a Very Successful New Year / 2018 Trading!

– Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 12/25/2017 – 12/29/2017:

1) VICL – Vical Incorporated – Trading Below Cash
a. Buy at < ~ $1.66
b. Sell at >~ $2.70
c. Catalysts:
1. Initiated Phase 3 Jun 2013. Enrollment due to be completed 3Q 2016. Topline data due 1Q2018. – ASP0113 Vaccine – Hematopoietic cell transplant recipients – Phase 3; 20180101; 20180331; http://www.vical.com/investors/news-releases/News-Release-Details/2016/Vical-Reports-Third-Quarter-2016-Financial-Results/default.aspx
2. Phase 3 trial completion announced November 10, 2017. Top-line data due 1Q 2018. – ASP0113 Vaccine – Hematopoietic cell transplant recipients – Phase 3; 20180331; 20180331; http://www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Reports-Third-Quarter-2017-Financial-and-Operational-Results/default.aspx
3. Phase 2 trial initiated September 2016. Enrollment completion announced April 19, 2017 with data due 2Q 2018. – VCL-HB01 HSV-2 Therapeutic Vaccine – Genital Herpes in Adults – Phase 2; 20180630; 20180630; http://www.vical.com/investors/news-releases/News-Release-Details/2017/Vical-Reports-Third-Quarter-2017-Financial-and-Operational-Results/default.aspx

2) EGLT – Egalet Corp – Trading Below Cash
a. Buy at < ~ $0.90
b. Sell at >~ $1.38
c. Catalysts:
1. Phase 3 to be completed 4Q 2017. NDA planned for 2018. – Egalet-002 – Moderate to severe chronic pain – Phase 3; 20171001; 20171231; http://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=11315453&type=HTML&symbol=EGLT&companyName=Egalet+Corporation&formType=8-K&dateFiled=2017-01-09

3) MBOT – Microbot Medical Inc
a. Buy at < ~ $1.00
b. Sell at >~ $1.50

4) PRSS – CafePress Inc
a. Buy at < ~ $1.67
b. Sell at >~ $2.20

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 12/25/2017 - 12/29/2017, and Why?

[Michael DeVries]

Here is another IMHO Must Read Article(s) for Traders:

“Trading Psychology Challenges – 9: Pessimism and Negativity” => https://traderfeed.blogspot.com/2017/12/trading-psychology-challenges-9.html

What do you all think about all of that?

Let’s talk about it all herein, ok?

I hope this helps! Good Luck! and Have a Great Trading Week!

– Michael S. DeVries

[Author]

Posts